EDIT:NASDAQ
Editas Medicine Inc
1,88 US$
arrow_upward
+0,80%(+0,015) 1D
17 ნოე, 11:38:25 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
290,93 მლნ.
Avg. vol.
2,41 მლნ.
Volume
593,01 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
290,93 მლნ.
Avg. vol.
2,41 მლნ.
Volume
593,01 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Stocks Gapping Down in Today's Session
TradingView
·
1 საათის წინ
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
Gadget Review
·
1 საათის წინ
Nearly 10% of the S&P 500 Depends on Just Three Men With No Clear Successors
Traders Union
·
22 წუთის წინ
S&P 500 trades near AVWAP and key retracement lines, Chris Ciovacco notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc